Patients With Cystic Echinococcosis Suspected Applicant Laboratory between 2005-2012 Anti-Echinococcus IgG IFA Seropositivity Designated Assessment Method

Volume: 5 Number: 2 December 1, 2013
  • Nezahat Akpolat
  • Mutalip Çiçek
  • Fatih Çakır
  • Şükran Can
  • Kadri Gül
EN

Patients With Cystic Echinococcosis Suspected Applicant Laboratory between 2005-2012 Anti-Echinococcus IgG IFA Seropositivity Designated Assessment Method

Abstract

Background: Cystic Echinococcosis is a significant health problem seen in our country and region, as well. Purpose: The purpose of the current study is to evaluate the anti-Echinococcus IgG seropositivity rates of the patients retrospectively who admitted to Dicle University, Department of Medical Microbiology Laboratory between January 2005 and June 2012 with the diagnosis of cystic echinococcosis. Method: The serum samples of 1612 patients 901 of whom were females and 711 males, sent to variety of clinics and polyclinics with the suspicion of cystic echinococcosis were studied. Indirect fluorescent antibody method was used in determining Echinococcus IgG antibodies (IFA). Results: The anti-Echinococcus IgG seropositivity was found to be 41.0% (662) in 1612 cases. 23.8% of seropositive patients were children and 76.1% of them were adults. Furthermore, seropositivity was detected in 43.3% of 901 females and 38.1% 711 of the males. Conclusion: The serological test can be implemented to support the radiological diagnosis of KE, to determine asymptomatic cyst carriers, the prevalence of disease in the community and, if there is to demonstrate the effectiveness of the control program. On the other hand, echinococcosis continues to be a common public health problem in our province.

Keywords

References

  1. Altıntaş N, Yazar S, Yolasığmaz A, Akısu C, Şakru N, Karacasu F, et al. A serum epidemiological study of cystic echinocococcosis in İzmir and its surrounding area. Turkey Helminthologia 1999; 36: 19 - 23. 2. Özbilgin A, Kilimcioğlu AA.Kistik Echinococcosis. Özcel MA, Özbel Y, Ak M, editors. Özcel’in Tıbbi Parazit Hastalıkları. İzmir: Meta basım;2007. 541-66. 3. Şenlik B. Echinococcosis. Altıntaş N, Tınar R, Çoker A, Edi. Hidatidoloji Derneği No: 1, 2004;31-37.
  2. Gottstein B. Molecular and immunological diagnosis of echinococcosis. Clin Microbiol Rev 1992; 5: 248-61. 5. Yazar S, Altıntaş N. Serodiagnosis of cystic echinococcosis in Turkey. Helminthologia 2003; 40: 9-13.
  3. Çetinkaya Z, Ciftci IH, Demirel R, Altındiş M, Ayaz E. A sero-epidemiologic study on cystic
  4. echinococcosis in Midwestern region of Turkey. Saudi Med J 2005; 26: 350-1.
  5. Kilimcioğlu AA, Ozkol M, Bayindir P, Girginkardeşler N, Ostan I, Ok UZ. The value of
  6. ultrasonography alone in screening surveys of cystic echinococcosis in children in Turkey. Parasitol Int 2006; 55: 273-5.
  7. Aydın M, Adıyaman G, Doğruman-Al F, Kuştimur S, Ozkan S.Determination of anti-echinococcus IgG
  8. antibodies by ELISA in patients with suspected hydatid cyst.Türkiye Parazitol Derg. 2012;36(2):61-4.

Details

Primary Language

English

Subjects

-

Journal Section

-

Authors

Nezahat Akpolat This is me

Mutalip Çiçek This is me

Fatih Çakır This is me

Şükran Can This is me

Kadri Gül This is me

Publication Date

December 1, 2013

Submission Date

December 1, 2013

Acceptance Date

-

Published in Issue

Year 2013 Volume: 5 Number: 2

APA
Akpolat, N., Çiçek, M., Çakır, F., Can, Ş., & Gül, K. (2013). Patients With Cystic Echinococcosis Suspected Applicant Laboratory between 2005-2012 Anti-Echinococcus IgG IFA Seropositivity Designated Assessment Method. International Archives of Medical Research, 5(2), 9-14. https://izlik.org/JA29CS88BY
AMA
1.Akpolat N, Çiçek M, Çakır F, Can Ş, Gül K. Patients With Cystic Echinococcosis Suspected Applicant Laboratory between 2005-2012 Anti-Echinococcus IgG IFA Seropositivity Designated Assessment Method. IAMR. 2013;5(2):9-14. https://izlik.org/JA29CS88BY
Chicago
Akpolat, Nezahat, Mutalip Çiçek, Fatih Çakır, Şükran Can, and Kadri Gül. 2013. “Patients With Cystic Echinococcosis Suspected Applicant Laboratory Between 2005-2012 Anti-Echinococcus IgG IFA Seropositivity Designated Assessment Method”. International Archives of Medical Research 5 (2): 9-14. https://izlik.org/JA29CS88BY.
EndNote
Akpolat N, Çiçek M, Çakır F, Can Ş, Gül K (December 1, 2013) Patients With Cystic Echinococcosis Suspected Applicant Laboratory between 2005-2012 Anti-Echinococcus IgG IFA Seropositivity Designated Assessment Method. International Archives of Medical Research 5 2 9–14.
IEEE
[1]N. Akpolat, M. Çiçek, F. Çakır, Ş. Can, and K. Gül, “Patients With Cystic Echinococcosis Suspected Applicant Laboratory between 2005-2012 Anti-Echinococcus IgG IFA Seropositivity Designated Assessment Method”, IAMR, vol. 5, no. 2, pp. 9–14, Dec. 2013, [Online]. Available: https://izlik.org/JA29CS88BY
ISNAD
Akpolat, Nezahat - Çiçek, Mutalip - Çakır, Fatih - Can, Şükran - Gül, Kadri. “Patients With Cystic Echinococcosis Suspected Applicant Laboratory Between 2005-2012 Anti-Echinococcus IgG IFA Seropositivity Designated Assessment Method”. International Archives of Medical Research 5/2 (December 1, 2013): 9-14. https://izlik.org/JA29CS88BY.
JAMA
1.Akpolat N, Çiçek M, Çakır F, Can Ş, Gül K. Patients With Cystic Echinococcosis Suspected Applicant Laboratory between 2005-2012 Anti-Echinococcus IgG IFA Seropositivity Designated Assessment Method. IAMR. 2013;5:9–14.
MLA
Akpolat, Nezahat, et al. “Patients With Cystic Echinococcosis Suspected Applicant Laboratory Between 2005-2012 Anti-Echinococcus IgG IFA Seropositivity Designated Assessment Method”. International Archives of Medical Research, vol. 5, no. 2, Dec. 2013, pp. 9-14, https://izlik.org/JA29CS88BY.
Vancouver
1.Nezahat Akpolat, Mutalip Çiçek, Fatih Çakır, Şükran Can, Kadri Gül. Patients With Cystic Echinococcosis Suspected Applicant Laboratory between 2005-2012 Anti-Echinococcus IgG IFA Seropositivity Designated Assessment Method. IAMR [Internet]. 2013 Dec. 1;5(2):9-14. Available from: https://izlik.org/JA29CS88BY

All articles published by DUJE are licensed under the Creative Commons Attribution 4.0 International License. This permits anyone to copy, redistribute, remix, transmit and adapt the work provided the original work and source is appropriately cited. 24456